GW Henssler & Associates Ltd. reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 5.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,754 shares of the healthcare conglomerate's stock after selling 102 shares during the quarter. GW Henssler & Associates Ltd.'s holdings in UnitedHealth Group were worth $886,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in UNH. Price T Rowe Associates Inc. MD increased its position in shares of UnitedHealth Group by 17.8% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 36,853,394 shares of the healthcare conglomerate's stock worth $18,929,009,000 after purchasing an additional 5,556,335 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its holdings in UnitedHealth Group by 1,682.4% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate's stock worth $1,372,606,000 after acquiring an additional 2,540,538 shares during the last quarter. Great West Life Assurance Co. Can bought a new stake in UnitedHealth Group during the 3rd quarter worth about $537,996,000. Jennison Associates LLC grew its holdings in UnitedHealth Group by 28.3% during the 3rd quarter. Jennison Associates LLC now owns 4,752,598 shares of the healthcare conglomerate's stock worth $2,400,252,000 after acquiring an additional 1,047,892 shares during the last quarter. Finally, FMR LLC boosted its stake in shares of UnitedHealth Group by 2.0% in the 2nd quarter. FMR LLC now owns 49,813,470 shares of the healthcare conglomerate's stock valued at $25,585,693,000 after purchasing an additional 998,214 shares during the last quarter. Institutional investors and hedge funds own 86.31% of the company's stock.

Insider Transactions at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 450 shares of the company's stock in a transaction that occurred on Wednesday, December 7th. The stock was sold at an average price of $542.30, for a total value of $244,035.00. Following the sale, the executive vice president now directly owns 8,736 shares in the company, valued at $4,737,532.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.40% of the company's stock.

Wall Street Analyst Weigh In

UnitedHealth Group Price Performance

UNH stock traded up $0.74 during midday trading on Tuesday, reaching $486.55. The company had a trading volume of 951,666 shares, compared to its average volume of 4,035,418. The company has a market capitalization of $454.61 billion, a price-to-earnings ratio of 22.93, a price-to-earnings-growth ratio of 1.37 and a beta of 0.73. The stock has a 50 day moving average price of $518.68 and a 200-day moving average price of $524.27. UnitedHealth Group Incorporated has a 1-year low of $436.51 and a 1-year high of $558.10. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.77 and a quick ratio of 0.82.

UnitedHealth Group (NYSE:UNH – Get Rating) last issued its earnings results on Friday, January 13th. The healthcare conglomerate reported $5.34 EPS for the quarter, topping the consensus estimate of $5.17 by $0.17. The firm had revenue of $82.79 billion during the quarter, compared to the consensus estimate of $82.53 billion. UnitedHealth Group had a return on equity of 27.04% and a net margin of 6.21%. The business's quarterly revenue was up 12.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $4.48 earnings per share. Equities research analysts expect that UnitedHealth Group Incorporated will post 24.9 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 13th. Stockholders of record on Monday, December 5th were issued a dividend of $1.65 per share. This represents a $6.60 annualized dividend and a dividend yield of 1.36%. The ex-dividend date was Friday, December 2nd. UnitedHealth Group's dividend payout ratio (DPR) is currently 31.15%.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Read More

• Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
• Intuit Is About To Make a Move, But Which Way?
• 3 Late January Earnings Plays With Pop Potential
• Low-Priced Stocks Still Paying Dividends
• Why is the Chipotle Stock Price Surging This Week?
• Is the Northrop Grumman Selloff an Opportunity?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Get Rating).

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.